ZEE Business
ZEE BUSINESS
हिंदी में पढ़ें  हिंदी में पढ़ें
Live TV
Live TV
  • India
    • Economy
    • Politics
    • Markets
  • World
    • Economy
    • Politics
    • Markets
  • Companies
    • Auto
    • Banking & Financial Services
    • Pharma
    • Energy
    • Infrastructure
    • Media
    • IT
    • Telecom
    • Consumer Products
    • Aviation
    • FMCG
  • Personal Finance
    • Income Tax Calculator
    • Personal Loan Calculator
    • Car Loan Calculator
    • Home Loan Calculator
  • Mutual Funds
  • Technology
  • Automobile
    • Cars
    • Bikes
  • Small Business
    • SME
    • Startups
  • videos
  • photos
  • Authors
  • More ...
    • VIDEOS
    • PHOTOS
    • AUTHORS
Home » Companies News

Lupin shares fall 2% despite receiving approval for Acotiamide tablets

Naresh Gupta, President, Lupin Limited said “We have a rich legacy of having introduced novel treatments to address unmet medical needs in the country. I am sure that the approval of Acotiamide would go a long way in addressing an otherwise common but unmet medical need for a safe and effective drug for the management of dyspepsia.” 

  • Twitter
  • Facebook
  • GPlus
Lupin shares fall 2% despite receiving approval for Acotiamide tablets
This would be a first-class product for Indian market for which Lupin will soon commence its promotion in this market. Photo: Pixabay
By ZeeBiz WebTeam
Updated: Mon, Aug 22, 2016
01:09 pm
Mumbai , ZeeBiz WebDesk
RELATED NEWS
Lupin recalls over 24,000 bottles of skin treatment drug from US Lupin recalls over 24,000 bottles of skin treatment drug from US
Stock investment update: Ace investor Rakesh Jhunjhunwala removes money in this pharma-major - What should you do? Stock investment update: Ace investor Rakesh Jhunjhunwala removes money in this pharma-major - What should you do?
Pharma sector outlook 2019 in India: Expect big recovery in New Year; IPCA, Divis Lab champions of 2018 Pharma sector outlook 2019 in India: Expect big recovery in New Year; IPCA, Divis Lab champions of 2018
An intelligent and patient-friendly chatbot is trained to help patients with health-related concerns: Rajeev Sibal, Lupin An intelligent and patient-friendly chatbot is trained to help patients with health-related concerns: Rajeev Sibal, Lupin
A third of pharmaceutical companies miss Q2 average estimate A third of pharmaceutical companies miss Q2 average estimate

Shares of Lupin slumped by nearly Rs 28 or 2% to Rs 1549.05 despite recieving approval for its Acotiamide 100 mg (milligram) tablets from the Central Drugs Standard Control Organisation (CDSCO). 

The stock price of Lupin opened at Rs 1570 lower from its previous closing of Rs 1577.25. 

Nearly 33,214 shares have been exchanged by investors on BSE index. 

The pharma major announced today that it has received approval for Acotiamide 100 mg tablets from the CDSCO to treat functional Dyspepsia. This would be a first-class product for Indian market for which Lupin will soon commence its promotion in this market. 

Naresh Gupta, President, Lupin Limited said “We have a rich legacy of having introduced novel treatments to address unmet medical needs in the country. I am sure that the approval of Acotiamide would go a long way in addressing an otherwise common but unmet medical need for a safe and effective drug for the management of dyspepsia.” 

Acotiamide is a first-in-class novel drug to be introduced into the Indian Pharmaceutical Market (IPM) which could benefit millions of patients suffering from Dyspepsia or Indigestion, amongst the most common stomach complaints encountered in clinical practice. 

Recently, the company also receieved United States Food and Drug Administration (FDA) approval for its US subsidiary, Gavis Pharmaceuticals LLC., U.S.A. (collectively Lupin) for its Potassium Chloride Extended Release Capsules. 

The company reported consolidated net profit of Rs 881.9 crore, registering growth of 55.12% yoy (year-on-year) and 17.93% qoq (quarter-on-quarter) for the quarter ended June 30, 2016.

 

 

 

 

TAGS:
LupinStocksPharmaBombay Stock Exchange (BSE)US Food and Drug Administration (USFDA)Central Drugs Standard Control Organisation (CDSCO)
RELATED NEWS
Lupin recalls over 24,000 bottles of skin treatment drug from US Lupin recalls over 24,000 bottles of skin treatment drug from US
Stock investment update: Ace investor Rakesh Jhunjhunwala removes money in this pharma-major - What should you do? Stock investment update: Ace investor Rakesh Jhunjhunwala removes money in this pharma-major - What should you do?
Pharma sector outlook 2019 in India: Expect big recovery in New Year; IPCA, Divis Lab champions of 2018 Pharma sector outlook 2019 in India: Expect big recovery in New Year; IPCA, Divis Lab champions of 2018
An intelligent and patient-friendly chatbot is trained to help patients with health-related concerns: Rajeev Sibal, Lupin An intelligent and patient-friendly chatbot is trained to help patients with health-related concerns: Rajeev Sibal, Lupin
A third of pharmaceutical companies miss Q2 average estimate A third of pharmaceutical companies miss Q2 average estimate

LATEST NEWS

Uri: The Surgical Strike box office collection silences this record of Sunny Deol's Gadar - Ek Prem Katha, Baahubali 2

7th Pay Commission: Government forms committee to look into pay hike demand of these 2.5 lakh employees

India's Forex reserves rises by over $150 mn

Loan against LIC policy: Get money fast at very low interest rate

HDFC National Pension System calculator: How much you can get with Rs 2000, Rs 5000, Rs 10,000, Rs 12,500 per month investment

Gully Boy box office collection: Ranveer Singh-Alia Bhatt film enters Rs 100-crore club

ESIC latest decisions: Contribution rates for employees, employers reduced; income limit for medical benefits raised

RRB NTPC Recruitment Notification 2019: Check salary, qualification, application fee, age limit, reservation details for 1.3 lakh posts

NASA clears SpaceX test flight to space station

Twitter co-founder Evan Williams steps down from board

  • India News
  • World News
  • Companies News
  • Market News
  • Personal Finance News
  • Technology News
  • Automobile News
  • Small Business News
  • Income Tax Calculator
  • Live TV
  • Videos
  • Photos
  • Author
  • Rss Feed
  • Advertise with us
  • Privacy Policy
  • Legal Disclaimer

Latest Trending Updates

  • Amazon Prime Day
  • Income Tax
  • Bharti Airtel
  • NPA
  • Home Loan

Trending Topics

  • Farm Loans
  • 7th Pay Commission
  • Sanitary Pads
  • National Stock Exchange
  • GST

Follow us on

zeebiz
zeebiz

Partner Sites

  • Zee News
  • Hindi News
  • Marathi News
  • Bengali News
  • Tamil News
  • Malayalam News
  • Gujarati News
  • Telugu News
  • Kannada News
  • DNA
  • WION
Copyright © Zee Media Corporation Ltd. All rights reserved